Clark Wealth Partners’s AbbVie ABBV Stock Holding History

Clark Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.02M	Sell	4,056 -47	-1%	-$10.1K	0.58%	27
2026 Q1	$892K	Buy	4,103 +139	+4%	+$30.8K	0.6%	22
2025 Q4	$906K	Hold	3,964	–	–	0.55%	23
2025 Q3	$906K	Buy	3,964 +129	+3%	+$26.3K	0.55%	23
2025 Q2	$712K	Sell	3,835 -112	-3%	-$20.8K	0.48%	31
2025 Q1	$827K	Sell	3,947 -52	-1%	-$10.1K	0.61%	21
2024 Q4	$711K	Buy	+3,999	New	+$735K	0.55%	25

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Clark Wealth Partners's ABBV Position: Q2 2026 in Review

Clark Wealth Partners reduced its AbbVie (ABBV) stake by 1.1% in Q2 2026, selling an estimated $10.1K and leaving 4,056 shares worth $1.02M. The position accounts for 0.58% of the portfolio, ranked #27.

Clark Wealth Partners first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 4,063 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Clark Wealth Partners held 4,056 shares of AbbVie worth $1.02M as of Q2 2026.
Clark Wealth Partners sold 47 AbbVie shares in Q2 2026, an estimated $10.1K.
AbbVie made up 0.58% of Clark Wealth Partners's portfolio in Q2 2026, its #27 holding.
Clark Wealth Partners first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
4,063 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Clark Wealth Partners's 13F filing for Q2 2026, filed 28 Jul 2026.